Peer–reviewed journal – Articles:
in “Life Sciences“ :
1.Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19 https://doi.org/10.1016/j.lfs.2020.118335
2. Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition https://www.sciencedirect.com/science/article/abs/pii/S0024320521004938
In “Molecules“:
3.The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might be Linked to HS Attachment Sites Many thanks to the academic Editors: Jean-Marc Sabatier, Jacques Fantini, Giangiacomo Torri and Diego Muñoz-Torrero. And all the 3 reviewers.
Conferences
Cell Symposium: Viruses in health and disease
March 19–21, 2023, Sitges, Spain
Title: D-xylose, a Heparan Sulfate Biosynthesis Stimulator, Has Antiviral Properties Against SARS-CoV-2 , ZIKV, HCMV and HIV-1 In-vitro
reference number: P1.25
************************
Patents
1- one patent application filed in France
************************
Preprints
https://doi.org/10.21203/rs.3.rs-2899786/v1